Could a lower dose of a common heart drug be safer and just as effective?
NCT ID NCT07273994
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study looks at whether a lower daily dose (100 mg) of the heart medication amiodarone can keep the heart beating normally after an electrical shock treatment for atrial fibrillation, compared to the standard dose (200 mg). The goal is to see if the lower dose works just as well but causes fewer side effects. About 312 adults with persistent atrial fibrillation will take part and be followed for 12 to 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital de la Santa Creu i Sant Pau
RECRUITINGBarcelona, 08025, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.